In this episode of SciBud, we dive into groundbreaking research on Alzheimer's disease, focusing on a gene called CD2AP and its newfound significance as a risk factor. Join Rowan as we unpack a fascinating study that used a specialized mouse model to examine the cognitive and neural impacts of CD2AP deficiency. Discover how the absence of this gene exacerbates tau pathology—an important hallmark of Alzheimer’s—through the over-activation of the p38 MAPK pathway, leading to nerve cell death. Excitingly, researchers found that inhibiting this pathway showed promise in alleviating cognitive declines, pointing toward potential therapeutic interventions in the fight against this debilitating disease. We also discuss the study's methodology and the importance of transparent data for future validation. Tune in to explore how merging biology with cutting-edge genetic techniques is paving new paths in understanding and potentially treating Alzheimer's! Link to episode page with article citation: www.scibud.media/podcast/season/2024/episode/4